Monoclonal Antibodies in Cancer Therapy
Georgetown University · Georgetown University Medical Center
Abstract
Monoclonal antibody-based immunotherapy is now considered to be a main component of cancer therapy, alongside surgery, radiation, and chemotherapy. Monoclonal antibodies possess a diverse set of clinically relevant mechanisms of action. In addition, antibodies can directly target tumor cells while simultaneously promoting the induction of long-lasting anti-tumor immune responses. The multifaceted properties of antibodies as a therapeutic platform have led to the development of new cancer treatment strategies that will have major impacts on cancer care. This review focuses on the known mechanisms of action, current clinical applications for the treatment of cancer, and mechanisms of resistance of monoclonal…
Citation impact
- FWCI
- 43.22
- Percentile
- 100%
- References
- 154
Authors
2Topics & keywords
- Monoclonal antibody
- Immunotherapy
- Immune system
- Cancer
- Antibody
- Monoclonal antibody therapy
- Medicine
- Immunology
- Good health and well-being